Prevalence and Correlates of Complementary and Alternative Medicine Use among Patients with Lung Cancer: A Cross-Sectional Study in Beirut, Lebanon

Table 2

Correlates of CAM use among study participants using simple and multiple logistic regression analyses ().

	Univariate logistic regression	Multiple logistic regression
Age (years)
55 years	1	1
>55 Years	0.39 (0.17–0.87)	0.61 (0.13–2.79)
Gender
Male	1	1
Female	1.02 (0.50–2.09)	2.07 (0.46–9.20)
Nationality
Non-Lebanese	1	1
Lebanese	1.41 (0.65–3.05)	7.9 (1.13–55.45)
Marital status
Single	1	1
Married/live in	2.13 (0.65–6.94)	6.20 (0.31–125.49)
Educational level
High school level	1	1
University level	1.37 (0.71–2.66)	0.67 (0.17–2.67)
Employment status
Employed	1	1
Retired	0.63 (0.28–1.37)	0.82 (0.21–3.24)
Unemployed	0.44 (0.19–0.98)	0.19 (0.034–0.89)
Type of health insurance
Insured (public/private)	1	1
Self-paying	1.64 (0.80–3.35)	13.54 (2.23–82.23)
Monthly Income
<1000	1	1
>1000	1.66 (0.82–3.37)	2.57 (0.66–10.02)
Duration of lung cancer
2-3 months	1	1
4–12 months	0.91 (0.39–2.11)	1.20 (0.22–6.42)
>1 year	0.79 (0.33–1.83)	0.39 (0.08–1.74)
Current status of lung cancer
Early/locally advanced	1	1
Metastatic	1.07 (0.47–2.41)	0.95 (0.28–3.20)
Family history of lung cancer
No	1	1
Yes	1.14 (0.52–2.48)	0.35 (0.07–1.62)
Suffer from other diseases (hypertension or CVD or COPD)
No	1	1
Yes	0.34 (0.17–0.68)	0.13 (0.03–0.52)

in this table represent odds ratios (OR) and their corresponding 95% confidence intervals (CI). OR and their corresponding 95% CI are bolded.